A civil cause of action for a minor injured by a gender transition procedure.
Impact
A key provision of AB502 is that it includes a 'safe harbor' clause for health care providers, which protects them from liability if they adhere to specific requirements before administering gender transition procedures. These include thorough documentation of the minor's perceived gender, certification by mental health professionals regarding treatment necessity, and obtaining informed consent from both the minor and their guardian. This framework aims to ensure that minors undergoing treatment are medically justified and adequately supported.
Summary
Assembly Bill 502 seeks to establish a civil cause of action against health care providers who perform gender transition procedures on individuals under 18 years of age, if those individuals suffer injuries related to such procedures. These injuries may be physical, psychological, emotional, or physiological, and the bill allows for civil suits to be filed by the minor or their guardian if such harm occurs. Notably, the bill mandates that any action under this provision must be initiated before the minor reaches 33 years of age.
Contention
The bill has sparked significant debate regarding its implications for minors seeking gender transition care. Proponents argue that it safeguards vulnerable individuals and imposes necessary checks on medical practices involving minors, reinforcing the importance of careful assessment prior to such irreversible treatments. Conversely, opponents argue that the bill could hinder access to essential medical care for transgender minors, exacerbate mental health challenges, and potentially lead to negative long-term outcomes by restricting treatment options at critical developmental stages.
Relating to health benefit plan coverage for and prohibitions on gender transitioning procedures and treatments provided to certain individuals; creating a criminal offense.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.